Name | 4-[(5-bromopyridin-2-yl)methyl]morpholine |
---|---|
Synonyms |
Morpholine, 4-[(5-bromo-2-pyridinyl)methyl]-
4-(5-bromo-pyridin-2-ylmethyl)-morpholine 5-bromo-2-(4-morpholinylmethyl)pyridine 4-[(5-Bromo-2-pyridinyl)methyl]morpholine 4-[(5-bromo-2-pyridinyl) methyl]morpholine |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 310.8±37.0 °C at 760 mmHg |
Molecular Formula | C10H13BrN2O |
Molecular Weight | 257.127 |
Flash Point | 141.7±26.5 °C |
Exact Mass | 256.021118 |
PSA | 25.36000 |
LogP | 0.71 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.579 |
~85% 294851-95-9 |
Literature: LOCUS PHARMACEUTICALS, INC. Patent: US2010/41642 A1, 2010 ; Location in patent: Page/Page column 21 ; |
~28% 294851-95-9 |
Literature: PROLYSIS LTD Patent: WO2009/74812 A1, 2009 ; Location in patent: Page/Page column 77 ; WO 2009/074812 A1 |
~62% 294851-95-9 |
Literature: Boehringer Ingelheim Pharmaceuticals, Inc. Patent: US6822093 B2, 2004 ; |
Precursor 5 | |
---|---|
DownStream 1 | |